FDA Approves First Oral Treatment for Postpartum Depression. August 04, 2023
https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depression
Woman suffering from Postpartum Depression murders baby the next day.
Today, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.